United Kingdom (UK) Targeted Sequencing and Resequencing Market (2025-2031) | Forecast, Industry, Segmentation, Trends, Share, Competitive Landscape, Size & Revenue, Value, Analysis, Outlook, Companies, Growth

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Targeted Sequencing and Resequencing Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Targeted Sequencing and Resequencing Market - Industry Life Cycle

3.4 United Kingdom (UK) Targeted Sequencing and Resequencing Market - Porter's Five Forces

3.5 United Kingdom (UK) Targeted Sequencing and Resequencing Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 United Kingdom (UK) Targeted Sequencing and Resequencing Market Revenues & Volume Share, By Application, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing adoption of precision medicine in the UK healthcare system

4.2.2 Advancements in sequencing technologies leading to cost reduction and improved efficiency

4.2.3 Growing research and development activities in genomics and personalized medicine

4.3 Market Restraints

4.3.1 Stringent regulations and data privacy concerns impacting market growth

4.3.2 High initial setup costs and ongoing maintenance expenses for sequencing equipment

4.3.3 Limited reimbursement policies for sequencing services in the UK

6.1 United Kingdom (UK) Targeted Sequencing and Resequencing Market, By Type

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Targeted Sequencing and Resequencing Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 United Kingdom (UK) Targeted Sequencing and Resequencing Market Revenues & Volume, By DNA-based Targeted Sequencing, 2021- 2031F

6.1.4 United Kingdom (UK) Targeted Sequencing and Resequencing Market Revenues & Volume, By RNA-based Targeted Sequencing, 2021- 2031F

6.2 United Kingdom (UK) Targeted Sequencing and Resequencing Market, By Application

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Targeted Sequencing and Resequencing Market Revenues & Volume, By Clinical Application, 2021- 2031F

6.2.3 United Kingdom (UK) Targeted Sequencing and Resequencing Market Revenues & Volume, By Plant and Animal Sciences, 2021- 2031F

6.2.4 United Kingdom (UK) Targeted Sequencing and Resequencing Market Revenues & Volume, By Drug Development, 2021- 2031F

6.2.5 United Kingdom (UK) Targeted Sequencing and Resequencing Market Revenues & Volume, By Others, 2021- 2031F

7.1 United Kingdom (UK) Targeted Sequencing and Resequencing Market Export to Major Countries

7.2 United Kingdom (UK) Targeted Sequencing and Resequencing Market Imports from Major Countries

8.1 Average turnaround time for sequencing services

8.2 Adoption rate of targeted sequencing in clinical settings

8.3 Number of partnerships and collaborations between sequencing service providers and research institutions

8.4 Rate of adoption of sequencing technologies in routine clinical practice

8.5 Percentage of healthcare budget allocated to genomic medicine initiatives in the UK

9.1 United Kingdom (UK) Targeted Sequencing and Resequencing Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 United Kingdom (UK) Targeted Sequencing and Resequencing Market Opportunity Assessment, By Application, 2021 & 2031F

10.1 United Kingdom (UK) Targeted Sequencing and Resequencing Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Targeted Sequencing and Resequencing Market Competitive Benchmarking, By Operating and Technical Parameters